Kangmei Pharmaceutical Co., Ltd. (SHA:600518)
China · Delayed Price · Currency is CNY 1.350
+0.020 (1.50%)
Oct 9, 2026, 3:00 PM CST
Kangmei Pharmaceutical Market Cap
Kangmei Pharmaceutical has a market cap or net worth of 18.67 billion as of October 9, 2026. It is the 5,494th most valuable company in the world and the 937th biggest in China. Its market cap has decreased by 33.17% in one year.
Market Cap
18.67B
Enterprise Value
17.53B
Revenue
4.97B
Global Rank
Country Rank
#937 China
PE Ratio
633.68
ChartMarket Cap Chart
Since March 19, 2001, Kangmei Pharmaceutical's market cap has increased from 2.58B to 18.67B, an increase of 624.02%. That is a compound annual growth rate of 8.05%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 18.67B | -29.32% |
| Dec 31, 2025 | 26.41B | -18.58% |
| Dec 31, 2024 | 32.44B | 25.81% |
| Dec 29, 2023 | 25.79B | -15.45% |
| Dec 30, 2022 | 30.50B | -28.80% |
| Dec 31, 2021 | 42.84B | 221.38% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Nhwa Pharmaceutical Co., LTD | 22.08B |
| Guangdong Zhongsheng Pharmaceutical | 21.66B |
| Tasly Pharmaceutical Group | 21.21B |
| Hybio Pharmaceutical | 20.94B |
| Jilin Aodong Pharmaceutical Group | 20.55B |
| Betta Pharmaceuticals | 20.38B |
| Shanghai Haoyuan Chemexpress | 19.86B |
| Chengdu Kanghong Pharmaceutical Group | 19.03B |